DDIAS overexpression promotes the progression of lung cancer, colon cancer, breast cancer, and HCC through various mechanisms, including DNA synthesis and repair, p53 signaling proliferation and metastasis, STAT3 activation, death ligand signaling, and drug resistance (Fig. 3). This evidence concerns the gene DDIAS and hepatocellular carcinoma.